Tyra Biosciences Inc
TYRA
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.49B
Close$
$1.20
95.2% downside
Current Fair Value
95.2% downsideOvervalued by 95.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.49 Billion |
|---|---|
| Enterprise Value | $1.42 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.01 |
| Beta | 0.77 |
| Outstanding Shares | 65,991,171 |
Return
| Return on Equity | -42.01% |
|---|---|
| Return on Assets | -38.75% |
| Return on Invested Capital | -41.05% |
Valuation & Multiples
| P/E Ratio | -10.39 |
|---|---|
| PEG | -16.72 |
| Price to Sales | - |
| Price to Book Ratio | 5.03 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -9.64 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.65
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.69
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.1418▼ 129.52% |
|---|---|
| Total Calls | 423,200▲ 109.92% |
| Total Puts | 60,000▼ 79.29% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 113.97%▲ 3.34% |
|---|---|
| Total Invested | $2.25B▼ 10.96% |
| Investors Holding | 177▲ 5.00% |
ESG Score
No data
About Tyra Biosciences Inc
2,021 employees